Search | VHL Search Portal

1.

Non-surgical ablation for breast cancer: an emerging therapeutic option.

Toi, Masakazu; Kinoshita, Takayuki; Benson, John R; Jatoi, Ismail; Kataoka, Masako; Han, Wonshik; Yamauchi, Chikako; Inamoto, Takashi; Takada, Masahiro.

Lancet Oncol ; 25(3): e114-e125, 2024 Mar.

Article in English | MEDLINE | ID: mdl-38423057

2.

A Prospective Study Evaluating the Accuracy of Indocyanine Green (ICG) Fluorescence Compared with Radioisotope for Sentinel Lymph Node (SLN) Detection in Early Breast Cancer.

Dumitru, Dorin; Ghanakumar, Sujit; Provenzano, Elena; Benson, John R.

Ann Surg Oncol ; 29(5): 3014-3020, 2022 May.

Article in English | MEDLINE | ID: mdl-35000084

3.

Extended endocrine therapy in early breast cancer: how long and who for?

Benson, John R; Jatoi, Ismail.

Future Oncol ; 16(1): 4327-4336, 2020 Jan.

Article in English | MEDLINE | ID: mdl-31802715

4.

Opportunities and priorities for breast surgical research.

Cutress, Ramsey I; McIntosh, Stuart A; Potter, Shelley; Goyal, Amit; Kirwan, Cliona C; Harvey, James; Francis, Adele; Carmichael, Amtul R; Vidya, Raghavan; Vaidya, Jayant S; Fairbrother, Patricia; Benson, John R; Reed, Malcolm W R.

Lancet Oncol ; 19(10): e521-e533, 2018 10.

Article in English | MEDLINE | ID: mdl-30303126

5.

Epidemiologic Signatures in Cancer.

Jatoi, Ismail; Benson, John R.

N Engl J Med ; 382(1): 95-96, 2020 01 02.

Article in English | MEDLINE | ID: mdl-31875512

6.

Tailoring breast cancer therapies to reduce mortality and improve quality of life: San Antonio Breast Cancer Symposium 2017 (part 1).

Benson, John R; Jatoi, Ismail.

Future Oncol ; 14(19): 1889-1892, 2018 Aug.

Article in English | MEDLINE | ID: mdl-30019918

7.

Tailoring breast cancer therapies to reduce mortality and improve quality of life: San Antonio Breast Cancer Symposium 2017 (part 2).

Benson, John R; Jatoi, Ismail.

Future Oncol ; 14(19): 1893-1896, 2018 Aug.

Article in English | MEDLINE | ID: mdl-30019940

8.

Highlights of the San Antonio Breast Cancer Symposium 2016: Part 2.

Benson, John R; Jatoi, Ismail.

Future Oncol ; 13(16): 1365-1369, 2017 Jul.

Article in English | MEDLINE | ID: mdl-28685613

9.

Highlights of the San Antonio Breast Cancer Symposium 2016.

Benson, John R; Jatoi, Ismail.

Future Oncol ; 13(15): 1291-1295, 2017 Jun.

Article in English | MEDLINE | ID: mdl-28650276

10.

De-escalation of axillary surgery in early breast cancer.

Jatoi, Ismail; Benson, John R; Toi, Masakazu.

Lancet Oncol ; 17(10): e430-e441, 2016 Oct.

Article in English | MEDLINE | ID: mdl-27733269

11.

Treatment of low-risk ductal carcinoma in situ: is nothing better than something?

Benson, John R; Jatoi, Ismail; Toi, Masakazu.

Lancet Oncol ; 17(10): e442-e451, 2016 Oct.

Article in English | MEDLINE | ID: mdl-27733270

12.

Management of women with a hereditary predisposition for breast cancer.

Jatoi, Ismail; Benson, John R.

Future Oncol ; 12(19): 2277-88, 2016 Oct.

Article in English | MEDLINE | ID: mdl-27384952

13.

Idiopathic granulomatous mastitis: presentation, investigation and management.

Benson, John R; Dumitru, Dorin.

Future Oncol ; 12(11): 1381-94, 2016 Jun.

Article in English | MEDLINE | ID: mdl-27067146

14.

Highlights of the San Antonio Breast Cancer Symposium 2015: part 2.

Benson, John R; Jatoi, Ismail.

Future Oncol ; 12(7): 897-900, 2016 Apr.

Article in English | MEDLINE | ID: mdl-26880386

15.

Highlights of the San Antonio Breast Cancer Symposium 2015: part 1.

Benson, John R; Jatoi, Ismail.

Future Oncol ; 12(7): 893-6, 2016 Apr.

Article in English | MEDLINE | ID: mdl-26880387

16.

Highlights of the San Antonio Breast Cancer Symposium 2020: part 1.

Benson, John R; Dumitru, Dorin; Jatoi, Ismail.

Future Oncol ; 17(21): 2693-2698, 2021 Jul.

Article in English | MEDLINE | ID: mdl-34058834

17.

Highlights of the San Antonio Breast Cancer Symposium 2020: part 2.

Benson, John R; Dumitru, Dorin; Jatoi, Ismail.

Future Oncol ; 17(21): 2699-2703, 2021 Jul.

Article in English | MEDLINE | ID: mdl-34058844

18.

Quality of life after breast-conserving surgery for women with non-low-risk ductal carcinoma in situ.

Benson, John R.

Lancet Oncol ; 21(5): 612-614, 2020 05.

Article in English | MEDLINE | ID: mdl-32203697

19.

Highlights of the San Antonio Breast Cancer Symposium 2019 Part 1: the challenges of tumor heterogeneity.

Benson, John R; Dumitru, Dorin; Jatoi, Ismail.

Future Oncol ; 16(21): 1497-1502, 2020 Jul.

Article in English | MEDLINE | ID: mdl-32469603

20.

Highlights of the San Antonio Breast Cancer Symposium 2019 Part 2: the challenges of tumor heterogeneity.

Benson, John R; Dumitru, Dorin; Jatoi, Ismail.

Future Oncol ; 16(21): 1503-1509, 2020 Jul.

Article in English | MEDLINE | ID: mdl-32469673

VHL Search Portal

Information and Knowledge for Health

Config filters

Your selection (0)

Export format:

Export:

Non-surgical ablation for breast cancer: an emerging therapeutic option.

A Prospective Study Evaluating the Accuracy of Indocyanine Green (ICG) Fluorescence Compared with Radioisotope for Sentinel Lymph Node (SLN) Detection in Early Breast Cancer.

Extended endocrine therapy in early breast cancer: how long and who for?

Opportunities and priorities for breast surgical research.

Epidemiologic Signatures in Cancer.

Tailoring breast cancer therapies to reduce mortality and improve quality of life: San Antonio Breast Cancer Symposium 2017 (part 1).

Tailoring breast cancer therapies to reduce mortality and improve quality of life: San Antonio Breast Cancer Symposium 2017 (part 2).

Highlights of the San Antonio Breast Cancer Symposium 2016: Part 2.

Highlights of the San Antonio Breast Cancer Symposium 2016.

De-escalation of axillary surgery in early breast cancer.

Treatment of low-risk ductal carcinoma in situ: is nothing better than something?

Management of women with a hereditary predisposition for breast cancer.

Idiopathic granulomatous mastitis: presentation, investigation and management.

Highlights of the San Antonio Breast Cancer Symposium 2015: part 2.

Highlights of the San Antonio Breast Cancer Symposium 2015: part 1.

Highlights of the San Antonio Breast Cancer Symposium 2020: part 1.

Highlights of the San Antonio Breast Cancer Symposium 2020: part 2.

Quality of life after breast-conserving surgery for women with non-low-risk ductal carcinoma in situ.

Highlights of the San Antonio Breast Cancer Symposium 2019 Part 1: the challenges of tumor heterogeneity.

Highlights of the San Antonio Breast Cancer Symposium 2019 Part 2: the challenges of tumor heterogeneity.